Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS‐CoV‐2

Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS‐CoV‐2

Abstract Objective Vaccines are a major achievement of science, and new vaccines against SARS‐CoV‐2 are protecting the entire population from a life‐threatening infection. Although several neurological complications or worsening of pre‐existing neurological conditions after vaccination have been obs...

Full description

Bibliographic Details
Main Authors:	Salvatore Iacono, Tommaso Piccoli, Paolo Aridon, Giuseppe Schirò, Valeria Blandino, Domenico Tarantino, Luisa Agnello, Marcello Ciaccio, Paolo Ragonese, Giuseppe Salemi
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51785

Similar Items

Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer’s Disease with Different Rate of Progression (RoP): A Preliminary Study
by: Valeria Blandino, et al.
Published: (2024-09-01)

A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
by: Giuseppe Schirò, et al.
Published: (2022-07-01)

Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience
by: Salvatore Iacono, et al.
Published: (2024-07-01)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
by: Salvatore Iacono, et al.
Published: (2023-05-01)

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
by: Antonia Pignolo, et al.
Published: (2021-12-01)

FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis
by: Concetta Scazzone, et al.
Published: (2021-03-01)

Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform
by: Luisa Agnello, et al.
Published: (2024-07-01)

Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis
by: Alessia Bianchi, et al.
Published: (2023-02-01)

The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review
by: Giuseppe Schirò, et al.
Published: (2023-03-01)

Biomarkers of Sepsis
by: Luisa Agnello, et al.
Published: (2023-01-01)

Cerebrospinal fluid penetration of tigecycline
by: Carlo Pallotto, et al.
Published: (2014-08-01)

Sleep quality and cerebrospinal fluid oxysterols in degenerative dementias: correlations and possible biomedical implications
by: Luca Pradotto, et al.
Published: (2024-12-01)

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid.
by: Emanuele Persichetti, et al.
Published: (2014-01-01)

Massive Cerebrospinal Fluid Leak of the Temporal Bone
by: Giannicola Iannella, et al.
Published: (2016-01-01)

Identification of <i>Prototheca</i> from the Cerebrospinal Fluid of a Cat with Neurological Signs
by: Gianvito Lanave, et al.
Published: (2023-11-01)

The immunological implication of the new vitamin D metabolism
by: Giulia Bivona, et al.
Published: (2018-10-01)

Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
by: Guido Maria Giuffrè, et al.
Published: (2023-10-01)

Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals
by: Laura M. Lilley, et al.
Published: (2022-08-01)

COVID-19 and Alzheimer’s Disease
by: Marcello Ciaccio, et al.
Published: (2021-02-01)

High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients
by: Alessandra Amato, et al.
Published: (2024-07-01)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
by: Tiziana Colletti, et al.
Published: (2021-02-01)

Cerebrospinal fluid-based spatial statistics: towards quantitative analysis of cerebrospinal fluid pseudodiffusivity
by: Yutong Chen, et al.
Published: (2024-07-01)

Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage
by: Maria Giulia Abate, et al.
Published: (2019-07-01)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
by: Pisani Valerio, et al.
Published: (2012-08-01)

Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine
by: Bruna Lo Sasso, et al.
Published: (2022-05-01)

Measuring respiratory and cardiac influences on blood and cerebrospinal fluid flow with real-time MRI
by: Maria Marcella Laganà, et al.
Published: (2022-11-01)

MicroRNA expression in the cerebrospinal fluid of dogs with and without cervical spondylomyelopathy
by: Daniella P. Vansteenkiste, et al.
Published: (2019-11-01)

SARS-CoV-2 related encephalitis requires documentation of the virus in the cerebrospinal fluid
by: Josef Finsterer
Published: (2022-12-01)

Status epilepticus and the presence of SARS‐COV‐2 in the cerebrospinal fluid: A case report
by: Sara Abdolahi, et al.
Published: (2022-08-01)

Interleukin-31 in serum and cerebrospinal fluid of dogs with syringomyelia
by: Laura Lemke, et al.
Published: (2023-11-01)

Comparison of methods for the quantification of albumin in serum and cerebrospinal fluid
by: Vanessa Pérez-del-Vallín, et al.
Published: (2020-01-01)

Cerebrospinal fluid shunt complications
by: E Güzelbağ, et al.
Published: (1997-07-01)

Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01)

Cerebrospinal Fluid Pressure and Glaucoma
by: Jost B Jonas, et al.
Published: (2013-01-01)

Borrelia valaisiana in Cerebrospinal Fluid
by: Eudoxia Diza, et al.
Published: (2004-09-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
by: Chiara Lucchi, et al.
Published: (2024-08-01)

Probing cerebrospinal fluid mobility for human brain clearance imaging MRI: water transport across the blood-cerebrospinal fluid barrier and mobility of cerebrospinal fluid in perivascular spaces
by: Matthias J.P. van Osch, et al.
Published: (2022-11-01)

Design of an Innovative Methodology for Cerebrospinal Fluid Analysis: Preliminary Results
by: Tommaso Schirinzi, et al.
Published: (2021-05-01)